EconomyWhat Went Wrong With Walmart?

Bloomberg’s Poonam Goyal said Walmart’s earnings miss was largely driven by weak pharmaceutical sales, affected by new federal negotiations intended to lower drug prices. She said both the company and investors expect the issue to keep weighing on sales, while competitive pricing could help ease concerns about slowing U.S. growth.